Volume 9, Issue 1 (January 2007) 9, 3–7; 10.1111/j.1745-7262.2007.00232.x
Evaluation and diagnostic testing of erectile dysfunction in the era of phosphodiesterase type 5 inhibitors
Kenneth Jacobsohn and Run Wang
Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA
Correspondence: Run Wang, MD, FACS, Department of Urology, University of Texas Health Science Center and MD Anderson Cancer Center, Houston, Texas 77030, USA. Fax: +1-713-500-7319. E-mail: Run.Wang@uth.tmc.edu
Received 24 April 2006; Accepted 30 July 2006.
Abstract |
The diagnosis and treatment of erectile dysfunction has changed dramatically since the availability of safe and effective oral therapies. Unfortunately, not all men can be adequately treated in this way, and might require more invasive testing to diagnose and treat the specific cause of their dysfunction. This review looks at the tests and strategies available for men who cannot be treated by oral therapy alone.
Keywords: erectile dysfunction, testing, treatment, diagnosis, phosphodiesterase type 5 inhibitors
Full Text |
PDF |
中文摘要 |
|
|
Browse: 2854 |
|